SERDA therapeutics

serda therapeutics is a joint venture company between smith & nephew international – one of the leading wound care companies – and nlc, the european healthtech venture builder. smith & nephew granted an exclusive license on its preclinically developed product to serda therapeutics. serda is developing this proprietary best-in-class fast and effective therapeutic product to treat burn injuries and chronic ulcers. the developmental prescription product of serda therapeutics is expected to bring fast and effective wound debridement, ease of use, high stability and low-moderate irritation potential, based on the preclinical data.